Andreas Kerschbaumer

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 40

Top Topics

Rheumatoid Arthritis

Top Venues

Annals of the rheumatic diseases

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Michael Markus Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, Kamran Ghoreschi, Massimo Gadina, Leonhard X Heinz, Josef S Smolen, Daniel Aletaha, John O'Shea, Arian Laurence
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Annals of the rheumatic diseases (2023)
Victoria Konzett, Andreas Kerschbaumer, Josef S Smolen, Eirik Klami Kristianslund, Sella Aarrestad Provan, Tore K Kvien, Daniel Aletaha
Definition of rheumatoid arthritis flare based on SDAI and CDAI. Annals of the rheumatic diseases (2023)
Andreas Kerschbaumer, Nina Maria Stimakovits, Josef S Smolen, Tijen Stefanova, Eva Chwala, Daniel Aletaha
Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis. Annals of the rheumatic diseases (2023)
Christian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, Milena Bond, Elvis Hysa, Dario Camellino, Lisa Ehlers, Andy Abril, Simone Appenzeller, Maria Cinta Cid, Bhaskar Dasgupta, Christina Duftner, Peter C Grayson, Bernhard Hellmich, Alojzija Hocevar, Tanaz A Kermani, Eric L Matteson, Susan P Mollan, Lorna Neill, Cristina Ponte, Carlo Salvarani, Sebastian Eduardo Sattui, Wolfgang Andreas Schmidt, Philip Seo, Josef S Smolen, Jens Thiel, Carlos Enrique Toro Gutiérrez, Madeline Whitlock, Frank Buttgereit
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Annals of the rheumatic diseases (2023)
Victoria Konzett, Andreas Kerschbaumer, Josef S Smolen, Daniel Aletaha
Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis. Annals of the rheumatic diseases (2023)
Kastriot Kastrati, Daniel Aletaha, Gerd-Rüdiger R Burmester, Eva Chwala, Christian Dejaco, Maxime Dougados, Iain B McInnes, Angelo Ravelli, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke J H Voshaar, Kevin L Winthrop, Josef S Smolen, Andreas Kerschbaumer
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD open 8 (2) (2022)
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert B M Landewe, Johannes Jw Bijlsma, Andreas Kerschbaumer, René Westhovens, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases 81 (7) (2022)
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B McInnes, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke Voshaar, Kevin L Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H S Choy, Catalin Codreanu, Bernard Combe, Mary K Crow, Maarten P T de Wit, Paul Emery, Roy M Fleischmann, Cem Gabay, Merete Lund Hetland, Kimmie L Hyrich, AnnaMaria Iagnocco, John Dudley Isaacs, Joel M Kremer, Xavier Mariette, Peter A Merkel, Eduardo F Mysler, Peter Nash, Michael T Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases (2022)
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Peter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer, Lisa Göschl, Felix Kartnig, Thomas Deimel, Andreas Kerschbaumer, Thomas Hummel, Barbara Kornek, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Markus Bonelli
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Annals of the rheumatic diseases 81 (12) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Josef S Smolen, Robert B M Landewe
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Geßl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Daniela Sieghart, Michael Markus Bonelli
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Annals of the rheumatic diseases (2022)
Andreas Kerschbaumer, Zaïda Iasha Rivai, Josef S Smolen, Daniel Aletaha
Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis. Annals of the rheumatic diseases 81 (10) (2022)
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Michael Markus Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Peter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial. Annals of the rheumatic diseases 81 (6) (2022)
Dennis G McGonagle, Alen Zabotti, Giovanni Damiani, Charlie Bridgewood, Gabriele De Marco, Andreas Kerschbaumer, Daniel Aletaha
Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free? Annals of the rheumatic diseases (2021)
Heidi J Siddle, Lara S Chapman, Kulveer Mankia, Codruța Zăbălan, Marios Kouloumas, Karim Raza, Marie Falahee, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery, Suzanne H Richards
Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Annals of the rheumatic diseases (2021)
Kulveer Mankia, Heidi Siddle, Andrea Di Matteo, Deshiré Alpizar-Rodriguez, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery
A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. RMD open 7 (3) (2021)
Kulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, Deshiré Alpizar-Rodriguez, Anca Irinel Catrina, Juan D Cañete, Andrew P Cope, Claire Immediato Daien, Kevin D Deane, Hani El Gabalawy, Axel Finckh, V Michael Holers, Marios Koloumas, Francesca Ometto, Karim Raza, Condruta Zabalan, Annette H M van der Helm van Mil, Dirkjan van Schaardenburg, Daniel Aletaha, Paul Emery
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Annals of the rheumatic diseases 80 (10) (2021)
Andreas Kerschbaumer, Josef S Smolen, Peter Nash, Thomas Dörner, Maxime Dougados, Roy M Fleischmann, Klaus Geissler, Iain B McInnes, Tsutomu Takeuchi, Michael Trauner, Kevin Winthrop, Maarten P T de Wit, Wolf-Henning Boehncke, Louise Falzon, Désirée Mfm van der Heijde
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. RMD open 6 (3) (2021)
Alexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, Désirée Mfm van der Heijde, Maxime Dougados, Ronald van Vollenhoven, Iain B McInnes, Johannes W Bijlsma, Gerd R Burmester, Maarten P T de Wit, Louise Falzon, Robert Landewé
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases 79 (6) (2020)
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, Maarten P T de Wit, Jette Primdahl, Iain McInnes, Désirée Mfm van der Heijde, Xenofon Baraliakos, Louise Falzon, Laure Gossec
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 79 (6) (2020)
Laure Gossec, Xenofon Baraliakos, Iain McInnes, Andreas Kerschbaumer, Maarten P T de Wit, Maxime Dougados, Jette Primdahl, Désirée Mfm van der Heijde, Josef S Smolen
Response to: 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al. Annals of the rheumatic diseases (2020)
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten P T de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Gerd R Burmester, Juan D Cañete, Nemanja S Damjanov, Tue Wenzel Kragstrup, Tore K Kvien, Robert B M Landewé, Rik Jozef Urbain Lories, Helena Marzo-Ortega, Denis Poddubnyy, Santiago Rodrigues Manica, Larissa Valor-Méndez, Douglas James Veale, Filip E Van den Bosch, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Annals of the rheumatic diseases 79 (6) (2020)
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy M Fleischmann, Klaus Geissler, Iain McInnes, Janet E Pope, Désirée Mfm van der Heijde, Michaela Stoffer-Marx, Tsutomu Takeuchi, Michael Trauner, Kevin L Winthrop, Maarten P T de Wit, Daniel Aletaha, Xenofon Baraliakos, Wolf-Henning Boehncke, Paul Emery, John D Isaacs, Joel Kremer, Eun Bong Lee, Walter P Maksymowych, Marieke Voshaar, Lai-Shan Tam, Yoshiya Tanaka, Filip van den Bosch, René Westhovens, Ricardo Xavier, Josef S Smolen
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the rheumatic diseases 80 (1) (2020)
Andreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, Désirée Mfm van der Heijde, Maxime Dougados, Ronald van Vollenhoven, Iain B McInnes, Johannes W J Bijlsma, Gerd R Burmester, Maarten P T de Wit, Louise Falzon, Robert Landewé
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the rheumatic diseases 79 (6) (2020)
Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Maarten P T de Wit, Daniel Aletaha, Martin Aringer, John Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Mario Humberto Cardiel, Diederik De Cock, Catalin Codreanu, Maurizio Cutolo, Christopher John Edwards, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques-Eric Gottenberg, Merete Lund Hetland, Thomas Wj Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller-Ladner, Eduardo F Mysler, José António Pereira Da Silva, Gyula Poór, Janet E Pope, Andrea Rubbert-Roth, Adeline Ruyssen-Witrand, Kenneth G Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases 79 (6) (2020)
Andreas Kerschbaumer, Josef S Smolen, Harald Herkner, Tijen Stefanova, Eva Chwala, Daniel Aletaha
Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology. Nature medicine 26 (6) (2020)
Xenofon Baraliakos, Laure Gossec, Iain McInnes, Andreas Kerschbaumer, Maarten P T de Wit, Maxime Dougados, Jette Primdahl, Désirée Mfm van der Heijde, Josef S Smolen
Response to: 'Correspondence on 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Fallon et al. Annals of the rheumatic diseases (2020)